Clinical Sensitivity of SARS-CoV-2 Nucleic Acid Amplification Tests for Diagnosing COVID-19 | Zendy

Jessica P. Ridgway | Zendy; Jennifer Pisano | Zendy; Emily Landon | Zendy; Kathleen G. Beavis | Zendy; Ari Robicsek | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Clinical Sensitivity of SARS-CoV-2 Nucleic Acid Amplification Tests for Diagnosing COVID-19

Author(s) -

Jessica P. Ridgway,

Jennifer Pisano,

Emily Landon,

Kathleen G. Beavis,

Ari Robicsek

Publication year - 2020

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofaa315

Subject(s) - medicine , covid-19 , nucleic acid amplification tests , virology , sars virus , sensitivity (control systems) , outbreak , infectious disease (medical specialty) , disease , electronic engineering , engineering , chlamydia trachomatis

Utilizing 34 348 severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) nucleic acid amplification test (NAAT) results from 2 health systems, we estimated the clinical sensitivity of a single SARS-CoV-2 NAAT. We found that SARS-CoV-2 NAAT has 82%-97% sensitivity for diagnosing coronavirus disease 2019 among symptomatic patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research